T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
1501
Medical Properties Trust
MPT
$2.51B
| $4.18M | ﹤0.01% |
196,222
+27,389
| +16% | +$589K |
|
|
DNMR
1502
DELISTED
Danimer Scientific, Inc.
DNMR
| $4.15M | ﹤0.01% |
+2,748
| New | +$4.46M |
|
1503
Beam Therapeutics
BEAM
$2.71B
| $4.15M | ﹤0.01% |
51,823
+41,630
| +408% | +$3.96M |
|
1504
Valvoline
VVV
$4.34B
| $4.13M | ﹤0.01% |
158,438
-5,418
| -3% | -$135K |
|
1505
Lamar Advertising Co
LAMR
$16B
| $4.12M | ﹤0.01% |
43,905
+2,657
| +6% | +$234K |
|
1506
Ingredion
INGR
$6.6B
| $4.12M | ﹤0.01% |
45,817
+1,861
| +4% | +$159K |
|
|
X
1507
DELISTED
US Steel
X
| $4.11M | ﹤0.01% |
157,174
+5,121
| +3% | +$101K |
|
1508
Jazz Pharmaceuticals
JAZZ
$15.8B
| $4.09M | ﹤0.01% |
24,903
-380,467
| -94% | -$62.6M |
|
1509
First Solar
FSLR
$24.6B
| $4.06M | ﹤0.01% |
46,484
+5,412
| +13% | +$496K |
|
1510
UGI
UGI
$7.61B
| $4.05M | ﹤0.01% |
98,862
+7,801
| +9% | +$302K |
|
|
CLGX
1511
DELISTED
Corelogic, Inc.
CLGX
| $4.04M | ﹤0.01% |
50,915
-3,583
| -7% | -$286K |
|
1512
BJs Wholesale Club
BJ
$12B
| $4.01M | ﹤0.01% |
89,354
+15,818
| +22% | +$664K |
|
1513
Zillow
ZG
$7.93B
| $3.97M | ﹤0.01% |
30,195
-4,579
| -13% | -$707K |
|
|
OPLN
1514
Openlane
OPLN
$4.38B
| $3.94M | ﹤0.01% |
262,988
+2,243
| +0.9% | +$38.2K |
|
|
SRC
1515
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $3.94M | ﹤0.01% |
92,778
+1,512
| +2% | +$61.9K |
|
|
SPR
1516
DELISTED
Spirit AeroSystems
SPR
| $3.94M | ﹤0.01% |
80,889
+7,694
| +11% | +$329K |
|
|
Y
1517
DELISTED
Alleghany Corp
Y
| $3.93M | ﹤0.01% |
6,276
+384
| +7% | +$238K |
|
1518
PMV Pharmaceuticals
PMVP
$66.1M
| $3.93M | ﹤0.01% |
+119,375
| New | +$4.71M |
|
1519
Americold
COLD
$4.28B
| $3.91M | ﹤0.01% |
101,649
+9,261
| +10% | +$333K |
|
1520
AGNC Investment
AGNC
$13B
| $3.88M | ﹤0.01% |
231,296
+59,768
| +35% | +$966K |
|
1521
Autoliv
ALV
$8.93B
| $3.86M | ﹤0.01% |
41,614
+2,800
| +7% | +$259K |
|
1522
Toronto Dominion Bank
TD
$204B
| $3.85M | ﹤0.01% |
59,112
-9,400
| -14% | -$574K |
|
1523
National Vision
EYE
$1.5B
| $3.84M | ﹤0.01% |
87,664
+2,320
| +3% | +$111K |
|
1524
Barings BDC
BBDC
$978M
| $3.83M | ﹤0.01% |
383,785
+44,300
| +13% | +$421K |
|
1525
Louisiana-Pacific
LPX
$5.17B
| $3.82M | ﹤0.01% |
68,888
-13,289
| -16% | -$602K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.